Language

Cart

Your cart is empty

Accessibility Statement

Premise

Legislative Decree no. 82 of 27 May 2022 implemented Directive (EU) 2019/882 of the European Parliament and of the Council of 17 April 2019 on accessibility requirements for products and services.

Guidelines on service accessibility, pursuant to Article 21 of Legislative Decree No. 82/2022.

The decree was published in the Official Journal (General Series No. 152 of 01-07-2022) and entered into force on 16 July 2022, but its provisions are effective from 28 June 2025.

UGA Nutraceuticals srl is committed to making its websites accessible in accordance with Italian Law No. 82 of 27 May 2022, which transposed Directive (EU) 2019/882 of the European Parliament and of the Council of 17 April 2019 on the accessibility requirements of products and services. This accessibility statement applies to the websites https://www.omegor.com/.

Compatibility status with requirements

The website https://www.omegor.com/ is partially compliant with the requirements of Annex A of UNI EN 301549:2018 (WCAG 2.1) due to the non-compliances and/or exceptions listed below. UGA Nutraceuticals srl, together with its suppliers, is conducting an analysis to take the necessary steps to make the affected sites accessible and compliant with the standard.

Inaccessible content

The following content is not accessible because it is not compatible with the underlying harmonized standard EN 301 549:

  • There are links without link text on many pages.
  • On a page there is a list element that is not part of a list.
  • On several pages, the contrast between text and background is too low.
  • Single pages contain unlabeled iframe elements. Navigating iframes with screen readers is difficult.
  • Several pages contain unlabeled form fields. It's difficult to navigate to the form fields with screen readers.
  • All the pages contain unlabeled buttons. It's difficult to navigate to the buttons with screen readers.
  • There are titles on many pages that either do not have a caption or contain the aria-hidden attribute and are therefore not accessible to screen readers.
  • There are invalid values ​​for the aria attribute on several pages. They aren't recognized by screen readers and therefore aren't displayed correctly.
  • The values ​​of the 'autocomplete' attributes are incorrect on a page. As a result, they may not be recognized by the browser.
  • On individual pages, there are focusable elements that are marked as decorative and are therefore accessible to assistive technologies, but which should actually be ignored.
  • On single pages, a parent element lacks corresponding child elements. This can confuse screen reader users, as they expect content that isn't there.
  • On many pages, there are particularly important areas that are marked with the "region" role but are not labeled. This means that screen reader users cannot recognize the purpose and content of the area.
  • There are interactive elements on all pages whose names aren't part of the labeling. This makes it difficult to control the website using voice control.
  • There are elements on individual pages that are assigned to a role but do not contain the required attributes. These elements may not display correctly with screen readers depending on their role.
  • There are lists on individual pages that contain items that do not belong in the lists. As a result, the lists may not be displayed correctly by assistive technologies.

Current and future code updates have been and will be developed in accordance with WCAG 2.2 guidelines. This declaration was created on June 26 , 2025. It was carried out using an assessment compliant with the requirements of Directive (EU) 2019/882 through a self-assessment conducted directly by the provider. The declaration was created using Eye-Able® technology from Web Inclusion GmbH . Further information about Web Inclusion GmbH is available at https://eye-able.com/it.

UGA Nutraceuticals srl is conducting an analysis with its vendors to make the necessary changes to make the affected sites accessible and compliant with regulations. UGA Nutraceuticals srl, aiming to progressively improve its web customer experience, has also proactively implemented the Eye-Able® SaaS software from Web Inclusion GmbH.
This feature allows for audits to scan individual pages of the site to identify digital barriers, providing compatible support that explains the error and suggests alternative code to correct it, and other tools that allow website users to use important features that can improve their navigation. The company is committed to developing past and future code evolutions in compliance with the WCAG 2.2 guidelines.

Feedback and contact details

Do you have a comment or note about the barriers on this site? Contact us. We'll explain what barriers exist. You can find out what exceptions we've made. We'll respond to your questions as quickly as possible, but no later than the legal deadline of one month. Thank you for your feedback. You can contact us at:

UGA Nutraceuticals SRL
Via L. Da Vinci 129C
06024 Gubbio
Gubbio
info@uganutraceuticals.com
Tel.: 0399000200

The email must include: First and last name; Address of the web page or section of the site or customer area that is the subject of the report; Clear and concise description of the problem encountered; Tools used (operating system, browser, assistive technologies).

AGID

In the event of an unsatisfactory response or failure to respond within thirty days to the notification or request, the interested party can send a report to AGID:

AGID
Liszt Street 21
00144 Rome
protocollo@pec.agid.gov.it
https://www.agid.gov.it

Disclaimer

The automatic check of web content was performed on June 26, 2025. The web content was accessed using Google Chrome version 136.0.7103.92. Generally, Web Inclusion GmbH cannot provide any guarantee for such checks due to differences in the source code, the use of a different web/app version, or use on a different operating system and/or web browser. A complete check also requires manual testing by the website operator.